Financially wobbly opioid drugmaker Insys agrees to pay $225M to settle government probes
After being found guilty of engaging in a bribery scheme to get doctors to prescribe its potent, addictive painkiller and duping insurers into paying for the opioid drug by a federal jury last month, former executives of the controversial Insys Therapeutics are being held accountable. The Phoenix, Arizona-based drugmaker $INSY has agreed to pay $225 million to settle the government’s separate criminal and civil investigations, the Department of Justice (DoJ) said on Wednesday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.